Bio Break: Understanding Limit of Detection and Limit of Quantification in Assay Development
Dive into the world of assay development with this informative episode of Bio Break, where Nick and Joris explore two critical concepts: Limit of Detection (LOD) and Limit of Quantification (LOQ). These terms might sound similar, but their implications for clinical diagnostics and medical devices are vastly different. Whether you’re an engineer, researcher, or product developer, this video sheds light on why both LOD and LOQ are vital in ensuring the precision and reliability of diagnostic tests.
Nick breaks down these acronyms, explaining how LOD refers to analytical sensitivity — essentially, how low your system can detect an analyte. Meanwhile, LOQ focuses on functional sensitivity, or how well the assay performs in real-world applications, considering variables like user handling, reagents, and diverse physiological conditions. With real-world examples, this discussion highlights the importance of understanding these thresholds to create accurate and effective diagnostic tools.
In this episode, learn about the rule of thumb engineers use to determine these limits: aiming for three standard deviations above the detection limit for LOD and a robust ten standard deviations for LOQ to ensure consistent results in practical settings. From engineering perspectives to real-world applications, Nick and Joris share insights that bridge the gap between theory and practice in assay development.
If you’re navigating the complexities of medical device or diagnostic development, this episode is a must-watch! With a focus on how engineering and functionality intersect in LOD and LOQ testing, you’ll gain actionable insights for your projects.
Key topics covered:
- What LOD and LOQ mean for assay development.
- Differences between analytical and functional sensitivity.
- The importance of statistical thresholds in diagnostic reliability.
Don’t miss out—watch now to elevate your understanding of assay performance metrics!
Understanding LOD and LOQ in Assay Development
Related Resources
In this special New Year’s episode of Bio Break, Joris van der Heijden and Nick Allan reflect on resolutions, persistence, and a 20-year journey to establish a new standard for biofilm testing in medical devices. Nick shares the story of his two-decade-long mission to develop a standardized test method for growing and monitoring biofilm on medical device surfaces.
In this festive episode of Bio Break, Joris and Nick bring a holiday twist to medical device innovation by discussing how modern technology could improve Santa’s health. Using a lighthearted analogy, they explore the challenges of managing conditions like diabetes and how advancements in drug delivery devices, such as Ozempic injection systems, could make a difference.
In this episode of Bio Break, Joris and Nick explore the fascinating ways microbes and nature inspire medical innovations, showing how these tiny organisms play an outsized role in advancing healthcare and biotechnology. From lifesaving antibiotics like penicillin to revolutionary technologies like CRISPR-Cas9, they dive deep into the surprising and transformative contributions of microbes to medicine, shedding light on their critical role in shaping modern science and improving patient outcomes.
In this episode of Bio Break, Joris van der Heijden and Nick Allan explore one of the most critical challenges in drug delivery device design: shear stress. When designing systems for biologics and gene therapies, avoiding shear stress is essential to ensure the viability and activity of biomolecules like proteins, antibodies, and viruses.